HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,290.00
-280.00 (-4.26%)
Mar 31, 2025, 3:30 PM KST

HLB Life Science Revenue

In the year 2024, HLB Life Science had annual revenue of 102.24B KRW with 4.34% growth. HLB Life Science had revenue of 28.68B in the quarter ending December 31, 2024, with 21.79% growth.

Revenue
102.24B
Revenue Growth
+4.34%
P/S Ratio
7.30
Revenue / Employee
705.10M
Employees
145
Market Cap
800.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024102.24B4.25B4.34%
Dec 31, 202397.99B-1.60B-1.61%
Dec 31, 202299.59B46.10B86.17%
Dec 31, 202153.49B-38.30B-41.73%
Dec 31, 202091.80B-22.22B-19.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Korea Electric Power 93.40T
Korea Gas 38.39T
Korea District Heating 3,530.49B
Korea Electric Power Industrial Development 367.53B
Samchully Co.,Ltd 5,120.53B
Daesung Energy 995.13B
Yesco Holdings 1,160.35B
Seoul City Gas 1,703.79B
Revenue Rankings